Purchases and Sales Made in Q3 2020 in Cyclacel Pharmaceuticals, Inc. (CYCC)
This table provides information about the institutional ownership of Cyclacel Pharmaceuticals, Inc. (CYCC) during Q3 2020. The information is specifically focused on institutions that hold shares of Cyclacel Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 16, 2020
Q3 2020
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
126KNew |
$604K - $815K
|
126K
$79.1K
|
|
|
Nov 04, 2020
Q3 2020
|
Raymond James Financial Services Advisors, Inc.
St. Petersburg, FL |
BUY
|
- |
15K+ 48.77% |
$72.2K - $97.4K
|
45.8K
$28.8K
|
|
|
Nov 12, 2020
Q3 2020
|
Ubs Group Ag
|
BUY
|
- |
2.99K+ 149600.0% |
$14.4K - $19.4K
|
2.99K
$1.89K
|
|
|
Aug 30, 2024
Q3 2020
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
BUY
|
- |
1K+ 50.0% |
$4.81K - $6.49K
|
3K
$1.89K
|
|
|
Nov 05, 2020
Q3 2020
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
22+ 4.36% |
$106 - $143
|
527
$332
|
|
|
Nov 13, 2020
Q3 2020
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 20, 2020
Q3 2020
|
Wedbush Securities Inc
|
SELL
|
- |
-288- 0.98% |
$1.39K - $1.87K
|
29K
$18.3K
|
|
|
Nov 16, 2020
Q3 2020
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-49.2KClosed |
$237K - $319K
|
0
$0
|
|
|
Nov 09, 2020
Q3 2020
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-49.7KClosed |
$239K - $323K
|
0
$0
|
|
|
Nov 13, 2020
Q3 2020
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-172KClosed |
$826K - $1.11M
|
0
$0
|